296 related articles for article (PubMed ID: 31403473)
1. Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.
Robinson JI; Weir WH; Crowley JR; Hink T; Reske KA; Kwon JH; Burnham CD; Dubberke ER; Mucha PJ; Henderson JP
J Clin Invest; 2019 Aug; 129(9):3792-3806. PubMed ID: 31403473
[TBL] [Abstract][Full Text] [Related]
2. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
3. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
4. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics investigation of
Fishbein SR; Robinson JI; Hink T; Reske KA; Newcomer EP; Burnham CD; Henderson JP; Dubberke ER; Dantas G
Elife; 2022 Jan; 11():. PubMed ID: 35083969
[No Abstract] [Full Text] [Related]
6. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
7. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
[No Abstract] [Full Text] [Related]
8. BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.
Solbach P; Chhatwal P; Woltemate S; Tacconelli E; Buhl M; Gerhard M; Thoeringer CK; Vehreschild MJGT; Jazmati N; Rupp J; Manns MP; Bachmann O; Suerbaum S
PLoS One; 2018; 13(5):e0196977. PubMed ID: 29738579
[TBL] [Abstract][Full Text] [Related]
9. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
[TBL] [Abstract][Full Text] [Related]
10. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
[TBL] [Abstract][Full Text] [Related]
13. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
[TBL] [Abstract][Full Text] [Related]
14. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
15. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
16. Bile salt metabolism is not the only factor contributing to
Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
[TBL] [Abstract][Full Text] [Related]
17. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
18. Shifts in the Gut Metabolome and
Fletcher JR; Erwin S; Lanzas C; Theriot CM
mSphere; 2018; 3(2):. PubMed ID: 29600278
[TBL] [Abstract][Full Text] [Related]
19. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model.
Li X; Kang Y; Huang Y; Xiao Y; Song L; Lu S; Ren Z
Biomed Pharmacother; 2021 May; 137():111290. PubMed ID: 33508620
[TBL] [Abstract][Full Text] [Related]
20. The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.
Lopez CA; Beavers WN; Weiss A; Knippel RJ; Zackular JP; Chazin W; Skaar EP
mBio; 2019 Nov; 10(6):. PubMed ID: 31744916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
